Tenet Healthcare Corporation $THC Stock Holdings Trimmed by Andra AP fonden

Andra AP fonden lowered its position in shares of Tenet Healthcare Corporation (NYSE:THC) by 90.5% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,600 shares of the company’s stock after selling 15,199 shares during the quarter. Andra AP fonden’s holdings in Tenet Healthcare were worth $325,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Norges Bank purchased a new stake in Tenet Healthcare in the 2nd quarter worth approximately $206,981,000. Boston Partners boosted its holdings in shares of Tenet Healthcare by 95.0% during the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock worth $398,949,000 after buying an additional 1,104,500 shares during the period. Alliancebernstein L.P. lifted its holdings in shares of Tenet Healthcare by 375.7% during the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after buying an additional 624,125 shares during the last quarter. Holocene Advisors LP acquired a new stake in Tenet Healthcare during the second quarter worth about $102,855,000. Finally, WCM Investment Management LLC lifted its holdings in shares of Tenet Healthcare by 244.4% during the 3rd quarter. WCM Investment Management LLC now owns 510,224 shares of the company’s stock worth $102,657,000 after acquiring an additional 362,083 shares during the period. 95.44% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, Director Nadja West sold 2,178 shares of the stock in a transaction on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the sale, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Wall Street Zen upgraded THC to a “Strong‑Buy,” signaling fresh buy-side interest and likely supporting demand for the stock. Article Title
• Positive Sentiment: Zacks and other outlets have raised near‑term earnings estimates (Q1/Q2 FY2026 and FY2026), which supports the company’s earnings trajectory and provides backing for current valuation assumptions. Article Title
• Neutral Sentiment: A Yahoo Finance piece questions whether it’s too late to buy after an ~89% one‑year rally — this is market commentary on valuation and investor sentiment rather than new company fundamentals, and can amplify volatility as investors reassess upside. Article Title
• Negative Sentiment: Zacks’ detailed notes are mixed: while they raised FY2026 and some near‑term quarter forecasts, they trimmed several FY2027 and late‑year quarterly estimates (Q3/Q4 2027 and FY2027), indicating analyst caution about longer‑term growth and limiting upward re‑rating potential. Article Title

Analyst Ratings Changes

Several analysts have recently commented on the company. Barclays increased their target price on Tenet Healthcare from $240.00 to $257.00 and gave the stock an “overweight” rating in a report on Friday, February 13th. Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. JPMorgan Chase & Co. increased their target price on Tenet Healthcare from $200.00 to $230.00 and gave the stock an “overweight” rating in a research note on Thursday, November 13th. Jefferies Financial Group lifted their price objective on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a report on Thursday, February 12th. Finally, Royal Bank Of Canada raised their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $247.67.

Tenet Healthcare Stock Performance

Shares of THC opened at $238.68 on Monday. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $240.83. The stock has a 50-day moving average of $206.02 and a 200-day moving average of $200.15. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The company has a market cap of $20.76 billion, a PE ratio of 15.41, a P/E/G ratio of 1.18 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The company had revenue of $5.53 billion for the quarter, compared to analysts’ expectations of $5.47 billion. During the same quarter in the previous year, the firm earned $3.44 earnings per share. Tenet Healthcare’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities research analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.